Comparison of Composite Lipid Indices in Patients with Obstructive Sleep Apnoea

Abstract

Our results support the use of LAP in clinical practice when evaluating cardiovascular risk in patients with OSA. However, the optimal cut-off value should be determined in large-scale follow-up studies.